Literature DB >> 23148616

Pro-metastatic tumor-stroma interactions in breast cancer.

Sharath Gangadhara1, Peter Barrett-Lee, Robert I Nicholson, Stephen Hiscox.   

Abstract

The vast majority of breast cancer-related deaths are due to metastatic disease. Reciprocal and complex interactions between epithelial tumor cells and the various components of the tumor microenvironment influence tumor progression and metastases although the molecular mechanisms underlying these metastasis-promoting effects are not fully characterized. Identifying and understanding pathways of tumor-stroma cross-talk are likely to lead to the development of novel prognostic biomarkers for metastasis and strategies to prevent metastasis at its earliest stages, resulting in improved patient outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23148616     DOI: 10.2217/fon.12.134

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  10 in total

1.  MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.

Authors:  Qian Jiang; Miao He; Shu Guan; Mengtao Ma; Huizhe Wu; Zhaojin Yu; Longyang Jiang; Yan Wang; Xingyue Zong; Feng Jin; Minjie Wei
Journal:  Tumour Biol       Date:  2015-11-04

2.  GT198 Expression Defines Mutant Tumor Stroma in Human Breast Cancer.

Authors:  Zheqiong Yang; Min Peng; Liang Cheng; Kimya Jones; Nita J Maihle; Nahid F Mivechi; Lan Ko
Journal:  Am J Pathol       Date:  2016-03-18       Impact factor: 4.307

3.  Distinguishing metastatic triple-negative breast cancer from nonmetastatic breast cancer using second harmonic generation imaging and resonance Raman spectroscopy.

Authors:  Ethan Bendau; Jason Smith; Lin Zhang; Ellen Ackerstaff; Natalia Kruchevsky; Binlin Wu; Jason A Koutcher; Robert Alfano; Lingyan Shi
Journal:  J Biophotonics       Date:  2020-04-20       Impact factor: 3.207

Review 4.  Characterization of the Tumor Microenvironment and Tumor-Stroma Interaction by Non-invasive Preclinical Imaging.

Authors:  Nirilanto Ramamonjisoa; Ellen Ackerstaff
Journal:  Front Oncol       Date:  2017-01-31       Impact factor: 6.244

5.  Crosstalk between stromal components and tumor cells of TNBC via secreted factors enhances tumor growth and metastasis.

Authors:  Kideok Jin; Niranjan B Pandey; Aleksander S Popel
Journal:  Oncotarget       Date:  2017-07-21

6.  A genomic ruler to assess oncogenic transition between breast tumor and stroma.

Authors:  Shubhada Dhage; Amanda Ernlund; Kelly Ruggles; Deborah Axelrod; Russell Berman; Daniel Roses; Robert J Schneider
Journal:  PLoS One       Date:  2018-10-16       Impact factor: 3.240

7.  Cancer-associated fibroblasts promote proliferation of endometrial cancer cells.

Authors:  Kavita S Subramaniam; Seng Tian Tham; Zahurin Mohamed; Yin Ling Woo; Noor Azmi Mat Adenan; Ivy Chung
Journal:  PLoS One       Date:  2013-07-26       Impact factor: 3.240

8.  Interactions between exosomes from breast cancer cells and primary mammary epithelial cells leads to generation of reactive oxygen species which induce DNA damage response, stabilization of p53 and autophagy in epithelial cells.

Authors:  Sujoy Dutta; Case Warshall; Chirosree Bandyopadhyay; Dipanjan Dutta; Bala Chandran
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

9.  Second-harmonic patterned polarization-analyzed reflection confocal microscopy of stromal collagen in benign and malignant breast tissues.

Authors:  Chukwuemeka Okoro; Varun Kelkar; Mayandi Sivaguru; Rajyasree Emmadi; Kimani C Toussaint
Journal:  Sci Rep       Date:  2018-11-02       Impact factor: 4.379

10.  Anti-nicastrin monoclonal antibodies elicit pleiotropic anti-tumour pharmacological effects in invasive breast cancer cells.

Authors:  Aleksandra Filipović; Ylenia Lombardo; Monica Faronato; Monica Fronato; Joel Abrahams; Eric Aboagye; Quang-De Nguyen; Barbara Borda d'Aqua; Anne Ridley; Andrew Green; Emad Rahka; Ian Ellis; Chiara Recchi; Natasa Przulj; Anida Sarajlić; Jean-Rene Alattia; Patrick Fraering; Mahendra Deonarain; R Charles Coombes
Journal:  Breast Cancer Res Treat       Date:  2014-09-24       Impact factor: 4.872

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.